“…Anaphase bridges often break [101,103], resulting in chromosomal alterations, such as amplifications, translocations, or deletions, which are biomarkers of genomic instability in malignant cells and used for diagnostic purposes in oncology [104]. After anaphase bridge breakage and fusion of uncapped chromosome ends, in the next interphase, breakage-fusion-bridge cycles initiate and propagate through several divisions, generating more alterations, such as aneuploidy, polyploidy, and genetic mutations [105][106][107][108]. Calado et al [109] provided direct clinical evidence that telomere shortening in hematopoietic progenitor cells, followed by breakage-fusion-bridge cycles, increases predisposition to malignant transformation in patients with aplastic anemia.…”